In a recent breakthrough, scientists have discovered new insights into how antibodies aggregate and what this might mean for therapeutic treatments. By analyzing the structure of a monoclonal antibody, they were able to see how it changes shape when exposed to different environmental conditions. They found that the antibody can form a variety of aggregates, such as dimers, trimers, and tetramers. These aggregates can be used to improve the efficiency of drug delivery or enhance the immune response to certain diseases. This discovery opens up new avenues for developing therapeutic treatments that rely on antibody aggregation.

Read Full Article Here

source: Phys.org